by Lish Schilter | May 17, 2023
BELLEVUE, Wash. – May 17, 2023 – Today Truveta, a leader in electronic health record (EHR) data and analytics, announces the expansion of its community to include new life science partners, including Reprieve Cardiovascular and SK Life Science, joining previously...
by Lish Schilter | May 11, 2023
New research published in JAMA Network Open shows changes in minoxidil prescribing following media attention about oral use for hair loss. BELLEVUE, Wash. – May 11, 2023 – Today Truveta announced a new research letter published in JAMA Network Open using de-identified...
by Ellie Lampton | Apr 12, 2023
Truveta’s clinical expert-led AI delivers the cleanest healthcare data, including structured concepts from clinician notes BELLEVUE, Wash. – April 12, 2023 – Today Truveta introduces the Truveta Language Model (TLM), a large-language, multi-modal AI model for...
by Ellie Lampton | Mar 22, 2023
Truveta’s 28 health system members provide over 16% of patient care in the United States. BELLEVUE and SEATTLE, Wash. – March 21, 2023 – Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial...
by Ellie Lampton | Mar 1, 2023
Expanded de-identified social drivers of health data in Truveta Studio empower new health equity scenarios to study health disparities and improve patient care. BELLEVUE, Wash. – February 28, 2023 – Truveta announced the expansion of its de-identified data to include...
